Horizon 2020 Ciarán Duffy
SMEs in Horizon 2020
Horizon 2020 is different A strong challenge-based approach, allowing applicants to have considerable freedom to come up with innovative solutions Emphasis on innovation, with continuing support for R&D Less prescriptive topics, strong emphasis on expected impact A strategic approach, with two-year work programmes (with disclaimer for 2015) Focus areas bring together different technologies, along entire innovation chain Cross-cutting issues mainstreamed (e.g. social sciences, gender, international cooperation)
Collaborative projects and SMEs/large industry Intended to facilitate collaborative research across Europe through transnational consortiums of industry, that consist of minimum of three different partners (legal entities) from three different EU member-states or countries associated to Horizon 2020. Same reimbursement rate for all*: Up to 100% of eligible cost (limited to maximum of 70% for innovation actions), 25% flat-rate for indirect costs
Leadership in enabling and industrial technologies (LEIT) (i) ICT including micro- and nano-electronics and photonics (ii) Nanotechnologies (iii) Advanced Materials (iv) Biotechnology (v) Advanced Manufacturing & Processing (vi) Space Access to risk finance Leveraging private finance and venture capital for R&I Innovation in SMEs Fostering all forms of innovation in all types of SMEs
Key Enabling Technologies Funded (KET) projects will be outcome oriented. - enable the development of new goods and services and restructuring of industrial processes to modernise EU industry LEIT projects to develop key technology building blocks and bring them closer to applications and market to pave way for industrial and commercial implementation. Proposal should describe Exploitation and/or business plans Engagement of partners along industrial value chain Standardisation IPR Dissemination of know-how Support for education and training Expected impact
SME Instrument
Health SME Instrument: Clinical validation of Biomarkers and/or diagnostic medical devices
The FAST TRACK To INNOVATION pilot (open in 2015) supports projects undertaking innovation from the demonstration stage through to market uptake 1. It covers piloting, test-beds, validation in real world/working conditions, pre-normative research and standard-setting 2. It targets relatively mature new technologies, concepts, processes and business models that need a last development step to reach the market and wider deployment
A maximum of 5 legal entities can participate in an FTTI project. At least one of the following minimum conditions shall be met: at least 60% of the overall budget of the proposal must be allocated to consortium partner(s) from industry the minimum number of industry participants must be 2 in a consortium of 3 or 4 partners, and 3 in a consortium of 5 partners. The maximum EU contribution per project is EUR 3 million. Proposals shall relate to the specific objective 'Leadership in enabling and industrial technologies' and/or to any of the specific objectives under the priority 'Societal challenges'. A proposal must include a business plan. For this pilot phase of the FTI, only applications involving entities all of whom must be established in the EU Member States or countries associated to Horizon 2020 are eligible.
FAST TRACK To INNOVATION: Value creation to be captured within 1 to 3 years (i.e. time to market introduction) High technology readiness level of TRL 6 or above Evaluating the 'impact' criterion first and stop the evaluation if the threshold of 4 or 5 is not reached Using mainly market and business analysts as expert evaluators
EUREKA EUROSTARS-II
EUREKA supports THREE types of projects Cluster Projects Long-term, strategically-significant initiatives Large number of participants, many from Europe s major companies Develop generic technologies of key importance to European competitiveness Individual Projects Small, shorter-term projects Involve participants from at least two member countries Result in a product, process or service with a significant advance in their sector Eurostars-II Projects Small, short-term projects, involving participants from at least two member States Consortium leader is an R&D-performing SME Programmed jointly with the European Commission
How does EUROSTARS-II work Two cut-off dates for applications per year Thursday 13 March 2014; 20:00 CET September 2014 On-line Application http://www.eurostars-eureka.eu Register with Eurostars to access What is required? Completed application form Certified Annual financial report or Business Plan Draft consortium agreement Ranking list produced from Evaluation at European level National agencies fund according to the ranking list (to the limit of the national budgets)
All applicants are strongly encouraged to contact their Eurostars National Project Coordinator before applying. Allowable Costs, grant rates, etc. are determined by National rules may differ in different countries. In Ireland: For established companies costs and funding are in line with EI R&D fund, Up to 50% grant rate for SMEs, 450,000 maximum grant for SMEs, 30% overhead on personnel costs Early stage & start-up companies may be funded through equity funding. Participants from Third level Institutes only funded if there is an Irish company as part of the consortium. 100% grant, up to max of 250,000 for Universities/Research Institutes Companies must have the resources to fund their 50% of project costs. National Authorities are required to submit an opinion on the capability of a participant to fund its portion of the project costs.
Strengths of EUROSTARS-II SME led projects must be led by an R&D performing SME Close to Market R&D must result in a product with 2 years from project end. Simple consortia minimum 2 entities from 2 different Eurostars member countries Bottom-up no themed calls, projects can be in any area
Marie Skłodowska-Curie Actions
RISE Action
Meet the Experts: www.horizon2020.ie
..thank you! Ciarán Duffy ciaran.duffy@enterprise-ireland.com 01-727 2760